TY - JOUR AU - Rahman, A. AU - Isenberg, D. A. PY - 2008 DA - 2008// TI - Systemic lupus erythematosus JO - N Engl J Med. VL - 358 UR - https://doi.org/10.1056/NEJMra071297 DO - 10.1056/NEJMra071297 ID - Rahman2008 ER - TY - JOUR AU - Gualtierotti, R. AU - Biggioggero, M. AU - Penatti, A. E. AU - Meroni, P. L. PY - 2010 DA - 2010// TI - Updating on the pathogenesis of systemic lupus erythematosus JO - Autoimmun Rev. VL - 10 UR - https://doi.org/10.1016/j.autrev.2010.09.007 DO - 10.1016/j.autrev.2010.09.007 ID - Gualtierotti2010 ER - TY - JOUR AU - Celhar, T. AU - Magalhães, R. AU - Fairhurst, A. M. PY - 2012 DA - 2012// TI - TLR7 and TLR9 in SLE: when sensing self goes wrong JO - Immunol Res. VL - 53 UR - https://doi.org/10.1007/s12026-012-8270-1 DO - 10.1007/s12026-012-8270-1 ID - Celhar2012 ER - TY - JOUR AU - Batteux, F. AU - Palmer, P. AU - Daëron, M. AU - Weill, B. AU - Lebon, P. PY - 1999 DA - 1999// TI - FCγRII (CD32)-dependent induction of interferon-α by serum from patients with lupus erythematosus JO - Eur Cytokine Netw. VL - 10 ID - Batteux1999 ER - TY - JOUR AU - Obermoser, G. AU - Pascual, V. PY - 2010 DA - 2010// TI - The interferon-α signature of systemic lupus erythematosus JO - Lupus. VL - 19 UR - https://doi.org/10.1177/0961203310371161 DO - 10.1177/0961203310371161 ID - Obermoser2010 ER - TY - JOUR AU - Iwata, Y. AU - Furuichi, K. AU - Kaneko, S. AU - Wada, T. PY - 2011 DA - 2011// TI - The role of cytokine in the lupus nephritis JO - J Biomed Biotechnol. VL - 2011 UR - https://doi.org/10.1155/2011/594809 DO - 10.1155/2011/594809 ID - Iwata2011 ER - TY - JOUR AU - Malek, T. R. PY - 2008 DA - 2008// TI - The biology of interleukin-2 JO - Annu Rev Immunol. VL - 26 UR - https://doi.org/10.1146/annurev.immunol.26.021607.090357 DO - 10.1146/annurev.immunol.26.021607.090357 ID - Malek2008 ER - TY - JOUR AU - Yuan, W. AU - DiMartino, S. J. AU - Redecha, P. B. AU - Ivashkiv, L. B. AU - Salmon, J. E. PY - 2011 DA - 2011// TI - Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes JO - Arthritis Rheum. VL - 63 UR - https://doi.org/10.1002/art.30083 DO - 10.1002/art.30083 ID - Yuan2011 ER - TY - JOUR AU - Burnstock, G. PY - 2011 DA - 2011// TI - Introductory overview of purinergic signalling JO - Front Biosci Elite Ed VL - 3 UR - https://doi.org/10.2741/e298 DO - 10.2741/e298 ID - Burnstock2011 ER - TY - JOUR AU - Fredholm, B. B. AU - Chern, Y. AU - Franco, R. AU - Sitkovsky, M. PY - 2007 DA - 2007// TI - Aspects of the general biology of adenosine A2A signaling JO - Prog Neurobiol. VL - 83 UR - https://doi.org/10.1016/j.pneurobio.2007.07.005 DO - 10.1016/j.pneurobio.2007.07.005 ID - Fredholm2007 ER - TY - JOUR AU - Fredholm, B. B. AU - IJzerman, A. P. AU - Jacobson, K. A. AU - Linden, J. AU - Müller, C. E. PY - 2011 DA - 2011// TI - International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update JO - Pharmacol Rev VL - 63 UR - https://doi.org/10.1124/pr.110.003285 DO - 10.1124/pr.110.003285 ID - Fredholm2011 ER - TY - JOUR AU - Burnstock, G. PY - 2007 DA - 2007// TI - Purine and pyrimidine receptors JO - Cell Mol Life Sci. VL - 64 UR - https://doi.org/10.1007/s00018-007-6497-0 DO - 10.1007/s00018-007-6497-0 ID - Burnstock2007 ER - TY - JOUR AU - Gessi, S. AU - Merighi, S. AU - Fazzi, D. AU - Stefanelli, A. AU - Varani, K. AU - Borea, P. A. PY - 2011 DA - 2011// TI - Adenosine receptor targeting in health and disease JO - Expert Opin Investig Drugs. VL - 20 UR - https://doi.org/10.1517/13543784.2011.627853 DO - 10.1517/13543784.2011.627853 ID - Gessi2011 ER - TY - JOUR AU - Antonioli, L. AU - Csóka, B. AU - Fornai, M. AU - Colucci, R. AU - Kókai, E. AU - Blandizzi, C. PY - 2014 DA - 2014// TI - Adenosine and inflammation: what’s new on the horizon? JO - Drug Discov Today. VL - 19 UR - https://doi.org/10.1016/j.drudis.2014.02.010 DO - 10.1016/j.drudis.2014.02.010 ID - Antonioli2014 ER - TY - JOUR AU - Virgilio, F. AU - Vuerich, M. PY - 2015 DA - 2015// TI - Purinergic signaling in the immune system JO - Auton Neurosci Basic Clin. VL - 191 UR - https://doi.org/10.1016/j.autneu.2015.04.011 DO - 10.1016/j.autneu.2015.04.011 ID - Virgilio2015 ER - TY - JOUR AU - Haskó, G. AU - Kuhel, D. G. AU - Chen, J. F. AU - Schwarzschild, M. A. AU - Deitch, E. A. AU - Mabley, J. G. PY - 2000 DA - 2000// TI - Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptor-dependent and independent mechanisms JO - FASEB J. VL - 14 UR - https://doi.org/10.1096/fj.99-0508com DO - 10.1096/fj.99-0508com ID - Haskó2000 ER - TY - JOUR AU - Schnurr, M. AU - Toy, T. AU - Shin, A. AU - Hartmann, G. AU - Rothenfusser, S. AU - Soellner, J. PY - 2004 DA - 2004// TI - Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells JO - Blood. VL - 103 UR - https://doi.org/10.1182/blood-2003-06-1959 DO - 10.1182/blood-2003-06-1959 ID - Schnurr2004 ER - TY - JOUR AU - Lappas, C. M. AU - Rieger, J. M. AU - Linden, J. PY - 2005 DA - 2005// TI - A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells JO - J Immunol. VL - 174 UR - https://doi.org/10.4049/jimmunol.174.2.1073 DO - 10.4049/jimmunol.174.2.1073 ID - Lappas2005 ER - TY - JOUR AU - Moore, C. C. AU - Martin, E. N. AU - Lee, G. H. AU - Obrig, T. AU - Linden, J. AU - Scheld, W. M. PY - 2008 DA - 2008// TI - An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models JO - BMC Infect Dis. VL - 8 UR - https://doi.org/10.1186/1471-2334-8-141 DO - 10.1186/1471-2334-8-141 ID - Moore2008 ER - TY - JOUR AU - Hochberg, M. C. PY - 1997 DA - 1997// TI - Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus JO - Arthritis Rheum. VL - 40 UR - https://doi.org/10.1002/art.1780400928 DO - 10.1002/art.1780400928 ID - Hochberg1997 ER - TY - JOUR AU - Gladman, D. D. AU - Ibañez, D. AU - Urowitz, M. B. PY - 2002 DA - 2002// TI - Systemic Lupus Erythematosus Disease Activity Index 2000 JO - J Rheumatol. VL - 29 ID - Gladman2002 ER - TY - JOUR AU - Zen, M. AU - Bassi, N. AU - Nalotto, L. AU - Canova, M. AU - Bettio, S. AU - Gatto, M. PY - 2012 DA - 2012// TI - Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study JO - Clin Exp Rheumatol. VL - 30 ID - Zen2012 ER - TY - JOUR AU - Harris, E. N. AU - Gharavi, A. E. AU - Patel, S. P. AU - Hughes, G. R. PY - 1987 DA - 1987// TI - Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986 JO - Clin Exp Immunol. VL - 68 ID - Harris1987 ER - TY - JOUR AU - Horbach, D. A. AU - Oort, E. AU - Donders, R. C. AU - Derksen, R. H. AU - Groot, P. G. PY - 1996 DA - 1996// TI - Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: comparison between different assays for the detection of antiphospholipid antibodies JO - Thromb Haemost. VL - 76 ID - Horbach1996 ER - TY - JOUR AU - Varani, K. AU - Padovan, M. AU - Vincenzi, F. AU - Targa, M. AU - Trotta, F. AU - Govoni, M. PY - 2011 DA - 2011// TI - A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release JO - Arthritis Res Ther. VL - 13 UR - https://doi.org/10.1186/ar3527 DO - 10.1186/ar3527 ID - Varani2011 ER - TY - JOUR AU - Varani, K. AU - Caramori, G. AU - Vincenzi, F. AU - Adcock, I. AU - Casolari, P. AU - Leung, E. PY - 2006 DA - 2006// TI - Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease JO - Am J Respir Crit Care Med. VL - 173 UR - https://doi.org/10.1164/rccm.200506-869OC DO - 10.1164/rccm.200506-869OC ID - Varani2006 ER - TY - JOUR AU - Varani, K. AU - Massara, A. AU - Vincenzi, F. AU - Tosi, A. AU - Padovan, M. AU - Trotta, F. PY - 2009 DA - 2009// TI - Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate JO - Arthritis Rheum. VL - 60 UR - https://doi.org/10.1002/art.24794 DO - 10.1002/art.24794 ID - Varani2009 ER - TY - JOUR AU - Varani, K. AU - Vincenzi, F. AU - Tosi, A. AU - Gessi, S. AU - Casetta, I. AU - Granieri, G. PY - 2010 DA - 2010// TI - A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson’s disease JO - FASEB J. VL - 24 UR - https://doi.org/10.1096/fj.09-141044 DO - 10.1096/fj.09-141044 ID - Varani2010 ER - TY - JOUR AU - Manderson, A. P. AU - Botto, M. AU - Walport, M. J. PY - 2004 DA - 2004// TI - The role of complement in the development of systemic lupus erythematosus JO - Annu Rev Immunol. VL - 22 UR - https://doi.org/10.1146/annurev.immunol.22.012703.104549 DO - 10.1146/annurev.immunol.22.012703.104549 ID - Manderson2004 ER - TY - JOUR AU - Shlomchik, M. J. AU - Craft, J. E. AU - Mamula, M. J. PY - 2001 DA - 2001// TI - From T to B and back again: positive feedback in systemic autoimmune disease JO - Nat Rev Immunol. VL - 1 UR - https://doi.org/10.1038/35100573 DO - 10.1038/35100573 ID - Shlomchik2001 ER - TY - JOUR AU - Robson, M. G. AU - Walport, M. J. PY - 2001 DA - 2001// TI - Pathogenesis of systemic lupus erythematosus (SLE) JO - Clin Exp Allergy. VL - 31 UR - https://doi.org/10.1046/j.1365-2222.2001.01147.x DO - 10.1046/j.1365-2222.2001.01147.x ID - Robson2001 ER - TY - JOUR AU - Zhang, L. AU - Yang, N. AU - Wang, S. AU - Huang, B. AU - Li, F. AU - Tan, H. PY - 2011 DA - 2011// TI - Adenosine 2A receptor is protective against renal injury in MRL/lpr mice JO - Lupus. VL - 20 UR - https://doi.org/10.1177/0961203310393262 DO - 10.1177/0961203310393262 ID - Zhang2011 ER - TY - JOUR AU - Yan, B. AU - Ye, S. AU - Chen, G. AU - Kuang, M. AU - Shen, N. AU - Chen, S. PY - 2008 DA - 2008// TI - Dysfunctional CD4+, CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-α-producing antigen-presenting cells JO - Arthritis Rheum. VL - 58 UR - https://doi.org/10.1002/art.23268 DO - 10.1002/art.23268 ID - Yan2008 ER - TY - JOUR AU - Oka, H. AU - Hirohata, S. PY - 1993 DA - 1993// TI - Regulation of human B cell responsiveness by interferon-α: interferon-α-mediated suppression of B cell function is reversed through direct interactions between monocytes and B cells JO - Cell Immunol. VL - 146 UR - https://doi.org/10.1006/cimm.1993.1023 DO - 10.1006/cimm.1993.1023 ID - Oka1993 ER - TY - JOUR AU - Zarek, P. E. AU - Huang, C. T. AU - Lutz, E. R. AU - Kowalski, J. AU - Horton, M. R. AU - Linden, J. PY - 2008 DA - 2008// TI - A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells JO - Blood. VL - 111 UR - https://doi.org/10.1182/blood-2007-03-081646 DO - 10.1182/blood-2007-03-081646 ID - Zarek2008 ER - TY - JOUR AU - Horwitz, D. A. AU - Gray, J. D. AU - Behrendsen, S. C. AU - Kubin, M. AU - Rengaraju, M. AU - Ohtsuka, K. PY - 1998 DA - 1998// TI - Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus JO - Arthritis Rheum. VL - 41 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Horwitz1998 ER - TY - JOUR AU - Chuang, H. C. AU - Lan, J. L. AU - Chen, D. Y. AU - Yang, C. Y. AU - Chen, Y. M. AU - Li, J. P. PY - 2011 DA - 2011// TI - The kinase GLK controls autoimmunity and NF-kB signaling by activating the kinase PKC-θ in T cells JO - Nat Immunol. VL - 12 UR - https://doi.org/10.1038/ni.2121 DO - 10.1038/ni.2121 ID - Chuang2011 ER -